Preclinical evaluation of a CXCR4-specific 68Ga-labelled TN14003 derivative for cancer PET imaging (original) (raw)
64Cu-AMD3100—A novel imaging agent for targeting chemokine receptor CXCR4
Ido Weiss
Bioorganic & Medicinal Chemistry, 2009
View PDFchevron_right
PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand
Horst Kessler
ChemMedChem, 2011
View PDFchevron_right
Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression
Ulrike Bauder-wüst
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors
Kazuma Ogawa
2006
View PDFchevron_right
High-Contrast CXCR4-Targeted 18FPET Imaging Using a Potent and Selective Antagonist
Jerome Lozada
View PDFchevron_right
PET of Tumor CXCR4 Expression with 4-18F-T140
Ido Weiss
Journal of Nuclear Medicine, 2010
View PDFchevron_right
Improvement of CXCR4 tracer specificity for PET imaging
Orit Jacobson
Journal of Controlled Release, 2012
View PDFchevron_right
N-[(11)C]Methyl-AMD3465 PET as a Tool for In Vivo Measurement of Chemokine Receptor 4 (CXCR4) Occupancy by Therapeutic Drugs
Siddesh Hartimath
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 2016
View PDFchevron_right
Nuclear (PET/SPECT) and optical imaging probes targeting the CXCR4 chemokine receptor
James Knight
MedChemComm, 2012
View PDFchevron_right
Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4
Stephan Maus
Scientia pharmaceutica, 2014
View PDFchevron_right
Positron emission tomographic imaging of CXCR4 in cancer: challenges and promises
Federica Pisaneschi
Molecular imaging, 2014
View PDFchevron_right
Development and Evaluation of an 18F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression
Marta Braga
Molecular Pharmaceutics, 2019
View PDFchevron_right
Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4)
Babak Azad, Lauren Woodard, Ala Lisok, Ronnie Mease
Nuclear Medicine and Biology, 2014
View PDFchevron_right
Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
Gilbert Green
Cancer Research, 2010
View PDFchevron_right
64Cu-Labeled Ubiquitin for PET Imaging of CXCR4 Expression in Mouse Breast Tumor
Dexing Zeng
ACS Omega
View PDFchevron_right
18F-labelling of a cyclic pentapeptide inhibitor of the chemokine receptor CXCR4
Federica Pisaneschi
Journal of Fluorine Chemistry, 2012
View PDFchevron_right
[68Ga]pentixafor for CXCR4 imaging in a PC-3 prostate cancer xenograft model – comparison with [18F]FDG PET/CT, MRI and ex vivo receptor expression
Oliver Hakenberg
Oncotarget
View PDFchevron_right
Cyclam te1pa for64Cu PET imaging. Bioconjugation to antibody, radiolabeling and preclinical application in xenografted colorectal cancer
Jean-François Gestin
RSC Advances, 2017
View PDFchevron_right
Scavenging strategy for specific activity improvement: application to a new CXCR4-specific cyclopentapeptide positron emission tomography tracer
Federica Pisaneschi
Journal of Labelled Compounds and Radiopharmaceuticals, 2013
View PDFchevron_right
64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist
cecilia miranda
Journal of Nuclear Medicine, 2019
View PDFchevron_right
Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis
Helmut Maecke
Journal of Nuclear Medicine, 2011
View PDFchevron_right
Imaging CXCR4 Expression with Iodinated and Brominated Cyclam Derivatives
Myat Ko Ko
Molecular Imaging and Biology, 2020
View PDFchevron_right
Molecular Imaging of Chemokine Receptor CXCR4
Ido Weiss
Theranostics
View PDFchevron_right
In Vivo Albumin-Binding of a C-Functionalized Cyclam Platform for 64Cu-PET/CT Imaging in Breast Cancer Model
Nathalie Le Bris
View PDFchevron_right
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging
Horst Kessler
Theranostics, 2015
View PDFchevron_right
99mTc-CXCR4-L for Imaging of the Chemokine-4 Receptor Associated with Brain Tumor Invasiveness: Biokinetics, Radiation Dosimetry, and Proof of Concept in Humans
Angélica Esperanza Arellano Zárate
Contrast Media & Molecular Imaging, 2020
View PDFchevron_right
N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging
Helmut Maecke
Journal of Nuclear Medicine, 2014
View PDFchevron_right
New Bifunctional Chelator p-SCN-PhPr-NE3TA for Copper-64: Synthesis, Peptidomimetic Conjugation, Radiolabeling, and Evaluation for PET Imaging
Dexing Zeng
Inorganic chemistry, 2016
View PDFchevron_right
Automated synthesis and quality control of [68Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
jerome clerc
View PDFchevron_right
Imaging cancer using PET — the effect of the bifunctional chelator on the biodistribution of a 64Cu-labeled antibody
Frederic Fahey, Erin Snay
Nuclear Medicine and Biology, 2011
View PDFchevron_right
Cyclam-Based Chelators Bearing Phosphonated Pyridine Pendants for 64Cu-PET Imaging: Synthesis, Physicochemical Studies, Radiolabeling, and Bioimaging
Loïc Charbonnière
Inorganic Chemistry, 2021
View PDFchevron_right
Evaluation of two novel 64Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ3
Francisco Valenzuela
European Journal of Nuclear Medicine and Molecular Imaging, 2015
View PDFchevron_right
In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study
Gilles Pagès
Biochemistry and Biophysics Reports, 2021
View PDFchevron_right